ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,336,878 | -78.0% | 464,450 | -75.1% | 0.02% | -79.5% |
| Q2 2023 | $37,913,002 | +8223.8% | 1,866,716 | +8375.4% | 0.08% | +8200.0% |
| Q4 2022 | $455,477 | -95.6% | 22,025 | -94.6% | 0.00% | -97.1% |
| Q2 2022 | $10,341,000 | +70.6% | 408,122 | +172.6% | 0.03% | +61.9% |
| Q4 2021 | $6,060,000 | +167.9% | 149,730 | +130.8% | 0.02% | +133.3% |
| Q3 2021 | $2,262,000 | +23.6% | 64,873 | -2.7% | 0.01% | 0.0% |
| Q2 2021 | $1,830,000 | -77.1% | 66,647 | -76.6% | 0.01% | -76.9% |
| Q1 2021 | $7,989,000 | +477.2% | 284,526 | +433.6% | 0.04% | +387.5% |
| Q4 2020 | $1,384,000 | -34.3% | 53,321 | -64.8% | 0.01% | -68.0% |
| Q1 2020 | $2,105,000 | – | 151,677 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |